Upregulated Claudin-18.2 Is a Poor Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy [0.03%]
Claudin-18.2高表达是术前同步放化疗直肠癌患者预后不良的标志
Chia-Lin Chou,Han-Ping Hsu,Wan-Shan Li et al.
Chia-Lin Chou et al.
Introduction: Claudins are essential for tight junctions, maintaining cell adhesion, regulating intercellular molecule movement, and preserving cellular polarity. Altered claudin expression can lead to dysfunctions, poten...
Application of a general LLM-based classification system to retrieve information about oncological trials [0.03%]
基于通用LLM的分类系统在检索肿瘤试验信息中的应用
Fabio Dennstädt,Paul Windisch,Irina Filchenko et al.
Fabio Dennstädt et al.
Purpose: The automated classification of clinical trials and key categories within the medical literature is increasingly relevant, particularly in oncology, as the volume of publications and trial reports continues to ex...
A Pipeline for the Automatic Identification of Randomized Controlled Oncology Trials and Assignment of Tumor Entities Using Natural Language Processing [0.03%]
基于自然语言处理的随机对照肿瘤临床试验自动识别及肿瘤类型赋值体系
Paul Windisch,Fabio Dennstädt,Carole Koechli et al.
Paul Windisch et al.
Background: Most tools trying to automatically extract information from medical publications are domain agnostic and process publications from any field. However, only retrieving trials from dedicated fields could have ad...
FDG-PET/CT and CT compared for evaluation of tumor response to first-line immunotherapy and prediction of prognosis in non-small-cell lung cancer patients [0.03%]
非小细胞肺癌患者一线免疫治疗后评估肿瘤缓解及预测预后的FDG-PET/CT与CT对比研究
Kazuhiro Kitajima,Kosuke Matsuda,Toshiyuki Minami et al.
Kazuhiro Kitajima et al.
Introduction: Immunotherapy-modified positron emission tomography response criteria in solid tumors (imPERCIST) using FDG-PET/CT and immune-related response evaluation criteria in solid tumors (irRECIST) using CT were com...
Impact of Obesity on Patients with Diffuse Large B-Cell Lymphoma Receiving CAR T-Cell Therapy [0.03%]
肥胖对接受CAR-T细胞治疗的弥漫性大B细胞淋巴瘤患者的影响
Jia Yi Tan,Yong Hao Yeo,Hermon Kha Kin Wong et al.
Jia Yi Tan et al.
Obesity has been associated with poorer outcomes in conventional cancer therapies. However, its impact on Chimeric Antigen Receptor (CAR) T-cell therapy for patients with diffuse large B-cell lymphoma (DLBCL) remains unclear. This study aim...
Assessment of the Factors Influencing Early Detection Practices of Oral Carcinomas by Dentists: A Cross-Sectional Study [0.03%]
评估影响牙医早期发现口腔癌因素的横断面研究
Zoofa Talha,Ishtiaq Ahmad,Aida Uzakova et al.
Zoofa Talha et al.
Introduction Oral cancer (OC) is the second most common type of cancer in Pakistan, and early diagnosis can improve survival rates. However, 75% of these cases are diagnosed at an advanced stage. To reduce the incidence and mortality associ...
Association between HER-2 and lymph node metastasis in gastric cancer: a meta-analysis [0.03%]
HER-2与胃癌淋巴结转移关系的meta分析研究
Yu-Ting Wang,Tao Guo,Ya Hui et al.
Yu-Ting Wang et al.
Human epidermal growth factor receptor 2 (HER-2) on the development of gastric cancer have been widely discussed in the literature. This meta-analysis aimed to assess the relationship between HER-2 and lymph node metastasis in gastric cance...
Evaluation of AI-Based Chatbots in Liver Cancer Information Dissemination: A Comparative Analysis of GPT, DeepSeek, Copilot, and Gemini [0.03%]
基于人工智能的聊天机器人在肝癌信息传播中的评估：对GPT、DeepSeek、Copilot和Gemini的比较分析
Mustafa Karaagac,Sedat Carkit
Mustafa Karaagac
Background/objectives: This study aimed to evaluate AI-based chatbots (GPT, DeepSeek, Copilot, Gemini) in disseminating information on liver cancer, emphasizing content quality, adherence to established guidelines, and ea...
Number of Tumors Stratifies the Therapeutic Response to Atezolizumab Plus Bevacizumab Therapy in Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: A Multicenter Analysis [0.03%]
巴塞罗那肝癌B期不可切除性肝细胞癌患者中，阿特珠单抗联合贝伐珠单抗治疗的疗效分级：一项多中心分析研究肿瘤数量对疗效的影响
Takanori Suzuki,Kentaro Matsuura,Daisuke Kato et al.
Takanori Suzuki et al.
Introduction: Atezolizumab plus bevacizumab (ATZ+BV) is used for the treatment of Barcelona Clinic Liver Cancer (BCLC) stage B unresectable hepatocellular carcinoma (u-HCC) patients. However, the efficacy of ATZ+BV in var...
Prognostic significance of modified Glasgow Prognostic Score in patients undergoing FOLFOXIRI plus bevacizumab therapy for advanced or metastatic colorectal cancer [0.03%]
改良版格拉斯哥预后评分对接受FOLFOXIRI联合贝伐单抗治疗的进展期或转移性结直肠癌患者预后的预测价值
Koji Numata,Yukari Ono,Kenta Iguchi et al.
Koji Numata et al.
Introduction: The prognostic value of the modified Glasgow Prognostic Score (mGPS), a systemic inflammatory response marker, has been reported in various cancers. However, its role in patients with metastatic colorectal c...